76783-60-3 Usage
Description
(3R,4S)-(-)-1-BENZYL-3,4-PYRROLIDINDIOL is a chiral, optically active chemical compound with a molecular formula of C13H17NO2. It possesses a specific stereochemical configuration and is often utilized as a starting material for the synthesis of various pharmaceutical and biologically active molecules. (3R,4S)-(-)-1-BENZYL-3,4-PYRROLIDINDIOL also serves as a chiral resolving agent in chromatography and for resolving racemic mixtures. Moreover, it has been investigated for its potential therapeutic effects, such as enzyme inhibition and anticancer properties, making it a significant compound in pharmaceuticals and medicinal chemistry.
Uses
Used in Pharmaceutical Synthesis:
(3R,4S)-(-)-1-BENZYL-3,4-PYRROLIDINDIOL is used as a starting material for the synthesis of various pharmaceutical and biologically active molecules. Its unique stereochemistry allows for the creation of enantiomerically pure compounds, which is crucial for ensuring the desired biological activity and minimizing potential side effects.
Used in Chiral Chromatography:
As a chiral resolving agent, (3R,4S)-(-)-1-BENZYL-3,4-PYRROLIDINDIOL is employed in chromatography to separate enantiomers, which is essential for the development and analysis of chiral drugs. The ability to distinguish between enantiomers is vital for understanding the different biological activities and pharmacokinetics of each enantiomer.
Used in Resolving Racemic Mixtures:
(3R,4S)-(-)-1-BENZYL-3,4-PYRROLIDINDIOL is used as a resolving agent for racemic mixtures, enabling the separation of enantiomers and facilitating the production of pure enantiomers for pharmaceutical applications.
Used in Enzyme Inhibition:
(3R,4S)-(-)-1-BENZYL-3,4-PYRROLIDINDIOL has been studied for its potential to inhibit certain enzymes, which could have therapeutic applications in treating various diseases and conditions.
Used in Anticancer Research:
(3R,4S)-(-)-1-BENZYL-3,4-PYRROLIDINDIOL has been investigated for its potential as an anticancer agent, with studies exploring its ability to target and inhibit the growth of cancer cells. Its use in oncology could lead to the development of new cancer treatments and therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 76783-60-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,7,8 and 3 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 76783-60:
(7*7)+(6*6)+(5*7)+(4*8)+(3*3)+(2*6)+(1*0)=173
173 % 10 = 3
So 76783-60-3 is a valid CAS Registry Number.
76783-60-3Relevant articles and documents
Processes and intermediates for preparing glycogen phosphorylase inhibitors
-
, (2008/06/13)
The instant invention provides novel processes and intermediates useful in the preparation of certain N-(indole-2-carbonyl)-β-alaninamide compounds, which compounds are glycogen phosphorylase inhibitors useful in the treatment of diseases such as hypercholesterolemia, hyperglycemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis, diabetes, diabetic cardiomyopathy, infection, tissue ischemia, myocardial ischemia, and in inhibiting tumor growth.
